4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001348362-25-000007
Options or other derivatives
- Chief Financial Officer acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Shankman Michael Elliot Chief Financial Officer | 2025-05-15 | Grant or award · Stock Options | +50,000 | 100,000 | D: show line 1 in the form |
Loading xslF345X05/primary_doc.xml…